Our mission is better health care outcomes.

Nephron Pharmaceuticals Corporation provides patients reliable access to affordable, high-quality medications through our innovative approach to sterile manufacturing.

Scroll Down

The Nephron Difference

Over 20 years expertise

We are a global leader in manufacturing generic respiratory medications and blow-fill-seal contract manufacturing. We are committed to the same level of excellence at our new 503B outsourcing facility.

State-of-the-art facilities

We were awarded a 2017 Facility of the Year distinction by the International Society for Pharmaceutical Engineering for our use of leading technologies, like laser guided vehicles and automated warehousing systems.

Industry-leading innovation

We have fully automated manufacturing, packaging, and distribution processes to limit contamination, and we can track all of our products throughout the supply chain to ensure patient safety.

""

Inhalation Products

Nephron Pharmaceuticals Corporation develops and manufactures safe, affordable inhalation solution and suspension products that help patients with respiratory ailments, such as asthma, emphysema, and chronic obstructive pulmonary disease. Nephron is a leader in manufacturing individually wrapped and bar-coded inhalation therapies, and the only manufacturer of Racemic Epinephrine, 2.25%, 0.5mL.

Product Information
Nephron facility external

503B Outsourcing

The Nephron 503B Outsourcing Facility is a cGMP manufacturer providing sterile, pre-filled medications to address persistent drug shortages in the United States. Our pre-filled syringes and small-volume parenteral solutions (SVPs), are packaged and designed to meet the needs of hospitals and other healthcare providers. The 503B Outsourcing division is built upon Nephron's 20+ years of sterile and automated manufacturing experience.

Learn More

Interested in Touring our Facility?

As a leading manufacturer of generic respiratory and 503B outsourcing medications, Nephron offers facility tours to ensure customers and business partners have complete satisfaction with the products and services we provide.

Click here to learn more about our Facility Tours.

Efficiency

Our state-of-the-art facilities give us the ability to produce over five million doses of life-saving medication every day.

Purity

Our automated manufacturing processes form, fill, and seal medications without human intervention in a controlled, sterile environment.

Efficacy

We are dedicated to creating better patient outcomes and producing life-saving products, ready for use on arrival.

Contract Manufacturing

Our manufacturing expertise and state-of-the-art ISO Class 5 and ISO Class 7 clean rooms enable us to facilitate even the most uncommon contract manufacturing requests.

Partner with Nephron

Celebrating 20 Years

On September 17, 1997, the FDA approved our first product, albuterol inhalation solution, and we began helping patients access affordable medication so they could breathe easier. Today, we’re a worldwide leader in manufacturing generic respiratory medications, and we’re rapidly expanding our facilities and capabilities. Twenty years later, we’re still united around the same mission to deliver safe, affordable medication to patients in need. We’re grateful to all those who helped us reach this important milestone, and we’re excited for the next 20 years of innovation at Nephron. 

Quotation Marks Inside Speech Bubble

I am grateful that Lou and Bill Kennedy see the University of South Carolina and our state as locations to further their commitment to pharmaceutical manufacturing with world class quality and efficiency.

Dr. Harris Pastides President, University of South Carolina
Quotation Marks Inside Speech Bubble

We prioritize patients’ needs by ensuring that our products are not only safe and effective from a clinical perspective, but also economical so that patients can afford their medication. In an industry where costs continue to increase, we believe this sets us apart from our competitors and positions us for ongoing success.

Lauren Delphia Senior Business Analyst, Nephron